Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

In this retrospective cohort study of a large population in Belgium, researchers aimed to examine endometrial cancer risk in patients with breast cancer who received tamoxifen.

Recent studies highlight the effectiveness of lenvatinib and pembrolizumab in improving overall survival for patients with ...

A University of Iowa student’s research is exploring new hormone therapies for uterine cancer. Five new progestins have shown more promise in lab tests than current clinical drugs. Her research helped ...

An international team including the National Cancer Center Japan analyzed trends in early-onset cancers diagnosed in 44 ...

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...

Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...

Daiichi Sankyo announced that the first patient has been dosed in the DESTINY-Endometrial02 phase 3 trial evaluating Enhertu (trastuzumab deruxtecan) with or without radiotherapy compared to standard ...

The first patient has been dosed in the DESTINY-Endometrial02 phase 3 trial evaluating ENHERTU ® (trastuzumab deruxtecan) with or without radiotherapy compared to standard of care chemotherapy with or ...

A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...

Explore the latest findings from the KATHERINE, PATINA, and HER2CLIMB-05 trials, highlighting advancements and challenges in breast cancer treatment.